Biodesix Return on Tangible Equity 2020-2025 | BDSX
Current and historical return on tangible equity values for Biodesix (BDSX) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Biodesix Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-09-30 | $-0.04B | $-0.02B | 318.37% |
| 2025-06-30 | $-0.04B | $-0.02B | 727.27% |
| 2025-03-31 | $-0.04B | $-0.01B | -1454.55% |
| 2024-12-31 | $-0.04B | $0.00B | 2150.00% |
| 2024-09-30 | $-0.04B | $0.01B | 676.92% |
| 2024-06-30 | $-0.05B | $0.01B | 315.79% |
| 2024-03-31 | $-0.05B | $-0.03B | 184.31% |
| 2023-12-31 | $-0.05B | $-0.02B | 221.28% |
| 2023-09-30 | $-0.06B | $-0.03B | 315.00% |
| 2023-06-30 | $-0.07B | $-0.03B | 318.07% |
| 2023-03-31 | $-0.07B | $-0.02B | 394.29% |
| 2022-12-31 | $-0.07B | $0.00B | 388.24% |
| 2022-09-30 | $-0.06B | $-0.03B | 332.39% |
| 2022-06-30 | $-0.06B | $-0.02B | 422.22% |
| 2022-03-31 | $-0.05B | $-0.02B | 547.37% |
| 2021-12-31 | $-0.04B | $-0.01B | 1563.64% |
| 2021-09-30 | $-0.04B | $-0.01B | -1555.56% |
| 2021-06-30 | $-0.03B | $0.00B | 49.23% |
| 2021-03-31 | $-0.03B | $0.01B | 44.96% |
| 2020-12-31 | $-0.03B | $0.01B | 47.94% |
| 2020-06-30 | $-0.03B | 0.00% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.064B | $0.071B |
| Biodesix Inc. is a data-driven diagnostic solutions company. It offers blood-based tests across the lung cancer continuum of care. The company also offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as develops and commercializes companion diagnostics. Biodesix Inc. is based in Boulder, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $168.818B | 31.00 |
| HCA Healthcare (HCA) | United States | $108.237B | 17.92 |
| CVS Health (CVS) | United States | $102.012B | 11.73 |
| Elevance Health (ELV) | United States | $83.333B | 12.22 |
| Cencora (COR) | United States | $66.377B | 21.40 |
| Natera (NTRA) | United States | $32.568B | 0.00 |
| DiDi Global (DIDIY) | China | $23.956B | 22.13 |
| Labcorp Holdings (LH) | United States | $20.757B | 15.83 |
| Medpace Holdings (MEDP) | United States | $16.879B | 41.90 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.455B | 0.00 |
| BioMerieux (BMXMF) | France | $15.505B | 0.00 |
| Solventum (SOLV) | United States | $14.863B | 14.43 |
| Viatris (VTRS) | United States | $14.604B | 5.44 |
| ICON (ICLR) | Ireland | $14.548B | 14.44 |
| Revvity (RVTY) | United States | $11.779B | 21.69 |
| CochLear (CHEOY) | Australia | $11.666B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.769B | 20.74 |
| Avantor (AVTR) | United States | $8.373B | 12.79 |
| Sonic Healthcare (SKHHY) | Australia | $7.695B | 0.00 |
| HealthEquity (HQY) | United States | $7.224B | 27.02 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.223B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $7.036B | 41.95 |
| PACS (PACS) | United States | $6.501B | 39.53 |
| Bausch + Lomb (BLCO) | Canada | $6.199B | 40.70 |
| Sotera Health (SHC) | United States | $5.395B | 26.01 |
| Alignment Healthcare (ALHC) | United States | $4.258B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.447B | 60.53 |
| Concentras Parent (CON) | United States | $2.642B | 16.49 |
| Progyny (PGNY) | United States | $2.450B | 48.17 |
| Organon (OGN) | United States | $2.111B | 2.22 |
| Surgery Partners (SGRY) | United States | $2.106B | 27.13 |
| Pediatrix Medical (MD) | United States | $1.946B | 11.62 |
| Establishment Labs Holdings (ESTA) | United States | $1.940B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.287B | 0.00 |
| Nutex Health (NUTX) | United States | $1.278B | 9.77 |
| Ardent Health (ARDT) | United States | $1.269B | 4.14 |
| CareDx (CDNA) | United States | $1.058B | 17.29 |
| GoodRx Holdings (GDRX) | United States | $0.978B | 16.00 |
| Omada Health (OMDA) | United States | $0.933B | 0.00 |
| Embecta (EMBC) | United States | $0.761B | 4.33 |
| InnovAge Holding (INNV) | United States | $0.754B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.672B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.602B | 0.00 |
| CryoPort (CYRX) | United States | $0.533B | 0.00 |
| Enhabit (EHAB) | United States | $0.516B | 23.16 |
| Strata Critical Medical (SRTA) | United States | $0.500B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.459B | 8.43 |
| Agilon Health (AGL) | United States | $0.409B | 0.00 |
| Oncology Institute (TOI) | United States | $0.379B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.358B | 75.29 |
| Auna S.A (AUNA) | Luxembourg | $0.355B | 5.70 |
| Shoulder Innovations (SI) | United States | $0.292B | 0.00 |
| So-Young (SY) | China | $0.278B | 0.00 |
| KindlyMD (NAKA) | United States | $0.203B | 0.00 |
| LifeMD (LFMD) | United States | $0.202B | 0.00 |
| Beauty Health (SKIN) | United States | $0.193B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.144B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.139B | 0.00 |
| DocGo (DCGO) | United States | $0.088B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.046B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
| Pomdoctor - (POM) | China | $0.032B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.24 |
| Intelligent Bio Solutions (INBS) | United States | $0.019B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Lifeward (LFWD) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |